Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease

Sponsor
Wake Forest University Health Sciences (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05972850
Collaborator
National Institute on Aging (NIA) (NIH)
40
1
1
10
4

Study Details

Study Description

Brief Summary

This pilot study will assess the feasibility and generate preliminary efficacy data of a novel, synchronous, home-based exercise training program for rural older adults with cardiovascular disease (CVD) using Vivo, an online, live, small group fitness program developed for older adults. It uses individually tailored dual-tasked (i.e., cognitive-motor) exercises to improve strength, endurance, balance, and cognition and incorporates social engagement. Certified trainers deliver instruction and coaching through an interactive session (45 min, 2-3 times/week) delivered over 12 weeks. Vivo Heart adapts this unique program to meet the cardiac rehabilitation needs of older adults with CVD. The specific aims are to evaluate the feasibility, acceptability, and uptake of Vivo Heart (Aim 1) and obtain pre- and post-intervention measures of exercise capacity, strength, lower-extremity physical function, cognition, quality of life, stress, fatigability, physical activity, and aging biomarkers (Aim 2).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Vivo Heart
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
40 rural-living older adults (60-80 years; Rural-Urban Commuting Area code 4-10) with a history of cardiovascular disease (prior myocardial infarction, angina, or coronary procedure) who are medically cleared for exercise by their cardiologist.40 rural-living older adults (60-80 years; Rural-Urban Commuting Area code 4-10) with a history of cardiovascular disease (prior myocardial infarction, angina, or coronary procedure) who are medically cleared for exercise by their cardiologist.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vivo Heart

This virtual intervention will include weekly group exercise sessions with a Vivo trainer (2 times/week), weekly health education classes with a registered dietitian (RD) (1 time/week), and two individual meetings with the RD over the course of 12 weeks. Participants will also be asked to complete a weekly aerobic exercise session on their own (1 time/week).

Behavioral: Vivo Heart
Vivo is an online, live, small group fitness program developed for older adults that uses individually tailored dual-tasked (i.e., cognitive-motor) exercises to improve strength, endurance, balance, and cognition and incorporates social engagement. Certified trainers deliver instruction and coaching through an interactive session for 45 min, 2-3 times/week.
Other Names:
  • Vivo
  • Outcome Measures

    Primary Outcome Measures

    1. Completion Rate [Week 12]

      Completion rate which will be determined by the percentage of enrolled participants who complete the study with ≥80% compliance.

    Secondary Outcome Measures

    1. Recruitment Rate [Year 1]

      Recruitment rate will be determined by the total number of enrolled participants divided by the number of months recruitment occurred.

    2. Recruitment Yield [Year 1]

      Recruitment yield will be determined based on the number of participants randomized relative to the total number of volunteers screened

    3. Compliance Rate [Week 12]

      Compliance will be determined based on adherence to the prescribed intervention. Compliance metrics will include attendance at the exercise sessions, health education classes, and dietary counseling sessions.

    4. Retention Rate [Week 12]

      Retention will be determined by the percentage of enrolled participations who complete follow-up testing.

    5. Satisfaction Survey Scores [Week 12]

      Acceptability will be assessed at the end of the study using a program satisfaction survey.

    6. Continuation Rate [Year 1]

      Uptake will be determined by the number of participants who continue in the Vivo program after the study is over.

    Other Outcome Measures

    1. VO2 peak [Week 12]

      Change in VO2 peak

    2. Montreal Cognitive Assessment (MoCA) [Week 12]

      Change in overall cognition (0-30)

    3. Digit Symbol Coding (DSC) [Week 12]

      Change in processing speed, working memory, visuospatial processing, and attention (secs)

    4. Timed Up and Go (TUG) [Week 12]

      Change in time to complete (secs)

    5. Expanded Short Physical Performance Battery (eSPPB) [Week 12]

      Change in score (0-4)

    6. The Four Square Step Test (FSST) [Week 12]

      Change in time to complete (secs)

    7. 4-step Stair Climb Test (4SCT) [Week 12]

      Change in time to complete (secs)

    8. Grip Strength [Week 12]

      Change in grip strength (kg)

    9. Perceived Stress Scale (PSS) [Week 12]

      Change in score

    10. Short Form-36 Health Survey (SF-36) [Week 12]

      Change in score

    11. UCLA Loneliness Scale [Week 12]

      Change in score

    12. Life Space [Week 12]

      Change in score

    13. Pittsburgh Fatigability Scale (PFS) [Week 12]

      Change in score

    14. Blood pressure [Week 12]

      Change in systolic and diastolic blood pressure (mmHg)

    15. Heart rate [Week 12]

      Change in resting heart rate (bpm)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 60 - 80 years

    • Rural-Urban Commuting Area code (RUCA) code 4-10

    • A qualifying Cardio Vascular Disease (CVD) event or procedure within the past 12 months

    • Cognitively unimpaired Telephone Interview for Cognitive Status (TICS-m ≥32)

    • No major depressive symptoms Patient Health Questionnaire (PHQ-8 <10)

    • Ambulatory and community-dwelling

    • Less than 150 min per week of moderate-to-intensive aerobic or resistance exercise in the past month

    • Medically cleared for exercise

    • Approved for participation by cardiologist

    • Access to a tablet or computer and internet/Wi-Fi in defined exercise space

    • Able to provide own transportation to study visits

    • Not participating in a clinical trial

    • Willing to provide informed consent

    Exclusion Criteria:
    • <60 years or >80 years

    • RUCA code 1-3

    • No CVD or a qualifying event or procedure >12 months ago

    • Dementia or severe cognitive impairment (TICS-m <32)

    • Clinical depression (PHQ-8 ≥10)

    • Non-ambulatory, institutionalized, or requires walker

    • Regular aerobic or resistance exercise (including current participation in a cardiac rehab program)

    • Not medically cleared for exercise

    • Advanced kidney disease requiring dialysis or dialysis anticipated within 6 months

    • Insulin-dependent diabetes

    • Use of any supplemental oxygen for COPD

    • Significant impairment from a prior stroke

    • Progressive neurologic disease (Parkinson's, ALS, multiple sclerosis, Alzheimer's disease, dementia)

    • Severe arthritis, fracture, chronic injury, or other musculoskeletal disorder that prevents walking independently

    • Cancer (not including non-melanoma skin cancers) requiring treatment with the past year

    • Excessive alcohol consumption (>7/week alcoholic beverages for women and >14/week for men) in the past month

    • Joint replacement or other orthopedic surgery in past 12 months or planned in next 6 months

    • No computer, tablet or internet access

    • No access to transportation for travel to study visits

    • Current participation in a clinical trial

    • Inability or unwillingness to comply with the study requirements

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Wake Forest University Health Sciences Winston-Salem North Carolina United States 27157

    Sponsors and Collaborators

    • Wake Forest University Health Sciences
    • National Institute on Aging (NIA)

    Investigators

    • Principal Investigator: Tina E Brinkley, PhD, Wake Forest University Health Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Wake Forest University Health Sciences
    ClinicalTrials.gov Identifier:
    NCT05972850
    Other Study ID Numbers:
    • IRB00094007
    • P30AG021332
    First Posted:
    Aug 2, 2023
    Last Update Posted:
    Aug 2, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Wake Forest University Health Sciences
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 2, 2023